References
- Alsarra IA, Alarifi MN. (2004). Validated liquid chromatographic determination of 5-Fluorouracil in human plasma. J Chromatogr B 804:435–39
- Ashford M, Fell T. (1994). Targeting drugs to colon: delivery system for oral administration. J Drug Target 2:241–58
- Basan H, Gumusderelioglu M, Tevfik Orbey M. (2007). Release characteristics of salmon calcitonin from dextran hydrogels for colon-specific delivery. Eur J Pharm Biopharm 65:39–46
- Bodmeier R, Wang J. (1993). Microencapsulation of drugs with aqueous colloidal polymer dispersions. J Pharm Sci 82:191–4
- Brondsted H, Andersen C, Hovgaard L. (1998). Crosslinked dextran—a new capsule material for colon targeting of drugs. J Control Rel 53:7–13
- Chaturvedi K, Ganguly K, Kulkarni AR, et al. (2013). Ultra-small fluorescent bile acid conjugated PHB–PEG block copolymeric nanoparticles: synthesis, characterization and cellular uptake. RSC Adv 3:7064–70
- Chaturvedi K, Kulkarni AR, Aminabhavi TM. (2011). Blend microspheres of poly(3-hydroxybutyrate) and cellulose acetate phthalate for colon delivery of 5-fluorouracil. Ind Eng Chem Res 50:10414–23
- Chaturvedi K, Tripathi SK, Kulkarni AR, Aminabhavi TM. (2013). Cytotoxicity and antitumour activity of 5-fluorouracil-loaded polyhydroxybutyrate and cellulose acetate phthalate blend microspheres. J Microencapsul 30:356–68
- Chourasia MK, Jain SK. (2003). Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharm Sci 6:33–66
- Dubernet C. (1995). Thermo analysis of microspheres. Thermochim Acta 248:259–69
- Ganguly K, Aminabhavi TM, Kulkarni AR. (2011). Colon targeting of 5-fluorouracil using polyethylene glycol cross-linked chitosan microspheres enteric coated with cellulose acetate phthalate. Ind Eng Chem Res 50:11797–807
- Hehre EJ, Sery TW. (1952). Dextran splitting anaerobic bacteria from the human intestine. J Bacteriol 63:424–6
- Hovgaard L, Brondsted H. (1995). Dextran hydrogels for colon-specific drug delivery. J Control Release 36:159–66
- Jain D, Majumdar DK, Panda AK. (2006). Insulin loaded eudragit L100 microspheres for oral delivery: preliminary in vitro studies. J Biomater Appl 21:195–211
- Krishnaiah YSR, Satyanarayan S. (2001). Colon-specific drug delivery systems. In: Jain NK, ed. Advances in controlled and novel drug delivery. : CBS Publishers and Distributors, 89–119
- Mateovic T, Kriznar B, Bogataj M, Mrhar A. (2002). The influence of stirring rate on biopharmaceutical properties of Eudragit RS microspheres. J Microencapsul 19:29–36
- Mehvar R. (2000). Dextrans for targeted and sustained delivery of therapeutic and imaging agents. J Control Release 69:1–25
- Michor F, Iwasa Y, Lengauer C, Nowak MA. (2005). Dynamics of colorectal cancer. Semin Cancer Biol 15:484–93
- Orienti I, Zecchi V. (1993). Progesterone-loaded albumin microparticles. J Control Release 21:1–7
- Paharia A, Yadav AK, Rai G, et al. (2007). Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting. AAPS Pharm Sci Technol 8:E1–7
- Rahman Z, Kohli K, Zhang SQ, et al. (2008). In vivo evaluation in rats of colon specific microspheres containing 5-fluorouracil. J Pharm Pharmacol 60:615–23
- Rai G, Jain SK, Agrawal S, et al. (2005). Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery. Pharmazie 60:131–4
- Rodriguez M, Vila-Jato JL, Torres D. (1998). Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Control Release 55:67–77
- Rokhade AP, Shelke NB, Patil SA, Aminabhavi TM. (2007). Novel hydrogel microspheres of chitosan and pluronic F-127 for controlled release of 5-fluorouracil. J Microencapsul 24:274–88
- Rubinstein A. (1990). Microbially controlled drug delivery to the colon. Biopharm Drug Dispos 11:465–75
- Simonsen L, Hovgaard L, Mortensen PB, Brøndsted H. (1995). Dextran hydrogels for colon-specific drug delivery. V. Degradation in human intestinal incubation models. Eur J Pharm Sci 3:329–37
- Sinha VR, Kumria R. (2001). Polysaccharides in colon-specific drug delivery. Int J Pharm 224:19–38
- Tsuchiya HM, Jeanes A, Bricker HM, Wilham CA. (1952). Dextran-degrading enzymes from molds. J Bacteriol 64:513–9
- Van den Mooter G, Samyn C, Kinget R. (1994). The relation between swelling properties and enzymatic degradation of azo polymers designed for colon-specific drug delivery. Pharm Res 11:1737–41
- Wei H, Qing D, De-Ying C, et al. (2008). Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats. Int J Pharm 348:35–45
- Yang L, Chu JS, Fix JA. (2002). Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm 235:1–15
- Youan BBC, Jacson TL, Dickens L, et al. (2001). Protein release profiles and morphology of biodegradable microcapsules containing an oily core. J Control Release 76:313–26
- Zumreoglu-Karan B, Mazi H, Guner A. (2002). Dextran–rare earth ion lnteractions. II. Solid-state characteristics. J Appl Polym Sci 83:2168–74